Washington, DC (PRWEB) June 20, 2012
For the first time in the 22 years since proton therapy has been clinically available to cancer patients, the National Association for Proton Therapy (NAPT) and the Proton Therapy Consortium, with the support of its proton community members, will host its first national conference (NPC2013) in Washington, D.C, February 11-14, at the Washington Marriott hotel, Metro Center.
“This first and foremost event will include participants from all the operating proton centers and all the top physicians focusing on ‘Improving Cancer Outcomes with Proton Therapy ‘with strong emphasis on broadening patient access, education, and collaboration,” announced Leonard Arzt, executive director of NAPT.
“NPC2013 will address the challenges and opportunities faced by institutions and organizations contemplating developing a proton center or now operating one,” Arzt noted. This educational forum will bring together administrators, physicians, medical physicists, health care economists, federal policymakers, reimbursement experts and marketing specialists to discuss trends, coverage issues, start-up tasks, and new proton technologies and many other topics.
“By meeting together in Washington, we intend to inform and educate all who envision expanding proton therapy access and improving cancer care for patients. Attendees will learn more about the work we do for the benefit of the patients we serve,” Arzt said.
NAPT is a nonprofit charitable corporation that serves as the Voice of of the Proton Community. It is the oldest, largest, and most recognized organization serving the proton community and is the number one global resource.
The mission of the Proton Therapy Consortium, also a nonprofit corporation, is to ensure availability and access to proton therapy for patients by educating regulators, payment providers, and policymakers on coverage issues. The Consortium also conducts independent studies.
The web page NPC2013.com will soon be available where additional program details will be posted confirming a prominent Washington keynote speaker and other presenters. After expenses, all proceeds from NPC2013 will support proton therapy education and awareness programs.